Valuation: Elekta AB (publ)

Market Cap 19.87B 2.05B 1.8B 1.67B 1.53B 2.9B 196B 2.96B 7.78B 96.16B 7.68B 7.51B 335B P/E 2027 *
13.9x
P/E 2028 * 12.4x
Enterprise Value 23.35B 2.4B 2.11B 1.96B 1.8B 3.4B 230B 3.48B 9.15B 113B 9.03B 8.83B 394B EV / Sales 2027 *
1.35x
EV / Sales 2028 * 1.26x
Free-Float
94.03%
Yield 2027 *
4.81%
Yield 2028 * 5.31%

Last Transcript: Elekta AB (publ)

Manager TitleAgeSince
Chief Executive Officer - 2025-08-31
Director of Finance/CFO - 2026-02-28
Investor Relations Contact - 2023-11-30
Director TitleAgeSince
Director/Board Member 69 2010-06-29
Director/Board Member 70 2011-09-14
Chairman 74 2013-09-02
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%-0.08% - - 2.04B
+0.28%+0.97%+21.54%+0.49% 196B
+0.08%-4.43%-20.49%+17.13% 144B
+0.56%+1.13%-2.29%-15.94% 141B
-0.27%-1.09%-56.73%-14.89% 66.54B
-0.46%-2.73%+17.60%-1.41% 53.09B
+2.80%+1.69%-22.83%-29.39% 44.12B
-0.19%+2.56%+8.73%+11.70% 37.93B
-0.85%-1.60%+5.76%+38.77% 36.96B
+0.94%-0.39%-13.07%-20.05% 29.43B
Average +0.43%-0.75%-6.87%-1.51% 83.21B
Weighted average by Cap. +0.33%-0.83%-3.67%-1.01%

Financials

2027 *2028 *
Net sales 17.35B 1.79B 1.57B 1.46B 1.34B 2.53B 171B 2.58B 6.8B 83.95B 6.71B 6.56B 292B 18.1B 1.86B 1.64B 1.52B 1.4B 2.64B 178B 2.7B 7.09B 87.61B 7B 6.85B 305B
Net income 1.43B 147M 129M 120M 110M 208M 14.04B 212M 559M 6.9B 551M 539M 24.05B 1.61B 165M 145M 135M 124M 234M 15.81B 239M 629M 7.77B 621M 607M 27.07B
Net Debt 3.48B 359M 315M 292M 269M 508M 34.29B 519M 1.36B 16.86B 1.35B 1.32B 58.73B 3B 309M 272M 252M 232M 438M 29.58B 448M 1.18B 14.54B 1.16B 1.14B 50.66B
Logo Elekta AB (publ)
Elekta AB (publ) is a Sweden-based medical technology company which aims to improve, prolong and save lives through clinical solutions for treating cancer and brain disorders. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The Company provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-